entertainment -WSS

entertainment

author：knowledge 2025-09-30 00:36:56 - browse：53

hazy pages of aetna.com layered next to each other, as shown through a kaleidoscopic glass — Adobe

CVS Health is preparing to make significant changes to its 2025 Medicare Advantage plans, which could potentially drive away 10% of its membership, the company’s chief financial officer said at an investment banking conference Tuesday.

“The goal for next year is margin over membership,” CVS CFO Tom Cowhey said at the conference, hosted by Bank of America. “Could we lose up to 10% of our existing Medicare members next year? That’s entirely possible. And that’s OK, because we need to get this business back on track.”

CVS, through its Aetna subsidiary, is the third-largest Medicare Advantage insurer, with more than 4.2 million enrollees as of April, according to the latest federal data. That means next year CVS could push out up to 420,000 older adults and people with disabilities on its Medicare Advantage plans, forcing them to choose another plan.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA scientists endorse Pfizer/BioNTech Covid

Wikipedia

WSS

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Antibody drugs appear effective. Now can we make enough of them?

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Personalized medicine goes far beyond genetics

H.R. 3 is the wrong path to lower drug costs

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

EU fines Illumina $475 million over Grail acquisition

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Physicians aren't 'burning out.' They're suffering from moral injury

United colonoscopy coverage change 'may cost lives,' doctors say

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How I helped Pfizer think through the ethics of Viagra

Novavax promises a turnaround & Lilly roils the obesity market

Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

Blinken talks high

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Chris Christie meets with Zelenskyy during Ukraine trip

FDA approves Sage Therapeutics’ rapid

Sickle cell gene therapy cures need to be accessible in Africa

Digital health funding stays low as a new reality sets in

focus

Wikipedia

hotspot

focus